Temporal Relationships Between Systemic Inflammatory Markers and Urinary I-FABP in Preterm Infants: Evidence that

Noura El Habbal1, Evgenia Jen Filatava2, Samer Charbaji3

  • 1Interdisciplinary Health Sciences, School of Health Professions, New York Institute of Technology, Old Westbury, NY, USA.

Insights

This study in preterm infants found that intestinal inflammation, measured by urinary intestinal fatty acid binding protein (I-FABP), is linked to systemic inflammation and may precede it. These findings offer insights into neonatal immune responses.

Area of Science:

  • Neonatal Immunology
  • Gastroenterology
  • Inflammation Research

Background:

  • Preterm infants have abnormal inflammatory responses, with unclear links between intestinal and systemic inflammation.
  • Understanding these inflammatory pathways is crucial for improving neonatal care and outcomes.

Purpose of the Study:

  • To investigate the association and temporal relationship between intestinal and systemic inflammation in preterm infants.
  • To analyze longitudinal trends of inflammatory markers over the first 20 weeks of life.

Main Methods:

  • Retrospective observational study of 74 preterm infants (<34 weeks gestation).
  • Collected urine and blood samples between 1-20 weeks of life.
  • Measured urinary intestinal fatty acid binding protein (I-FABP) for intestinal inflammation and CRP, ICAM-1, IL-1β, IL-6, IL-8 for systemic inflammation.
  • Utilized linear mixed-effects models to assess concurrent and lagged associations.

Main Results:

  • Longitudinal analyses showed decreasing trends in I-FABP, IL-6, and IL-8, and increasing trends in ICAM-1 over time.
  • Urinary I-FABP was concurrently associated with most systemic inflammatory markers (except CRP).
  • Lagged analysis indicated that elevated I-FABP levels one week prior were significantly associated with increased ICAM-1, IL-1β, and IL-8, suggesting intestinal inflammation precedes systemic inflammation.

Conclusions:

  • Significant associations exist between intestinal inflammation (urinary I-FABP) and systemic inflammatory markers in preterm infants.
  • Findings suggest a potential temporal progression from intestinal to systemic inflammation.
  • This provides novel insights into inflammatory dynamics and immune responses in this vulnerable population.

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...